Together, circadian control of intracellular copper supports GSC resistance to cuproptosis by coordinating BMAL1-dependent copper homeostasis, ATP7A-driven fatty acid desaturation, and copper-mediated BMAL1 degradation, revealing a targetable circadian-copper vulnerability in GBM (Figure 8D). The gene discussed is ATP7A; the disease is glioblastoma.